Skip to main content

Table 4 Influence of BMI stratum on the effect of FPV/r on the serum cholesterol level after 6 months of PI therapy

From: Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients

Parameter Coefficient p-value
ATV/r reference  
SQV/r 36.6 0.004
FPV/r   
    for BMI >23.5 kg/m2 58.1 <0.001
    for BMI ≤23.5 kg/m2 36.6 0.023
Serum cholesterol at baseline 0.5 <0.001
BMI of >23.5 kg/m 2 at baseline 15.0 0.13